Search filters

List of works by Luana Calabro'

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

scientific article

Biomarkers for immune checkpoint inhibitors – Authors' reply

scientific article published on 01 January 2014

CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy?

scientific article

Circulating haemopoietic and endothelial progenitor cells are decreased in COPD

scientific article published on 01 March 2006

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.

scientific article

Differential levels of soluble endoglin (CD105) in myeloid malignancies

scientific article published on 01 February 2003

Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study.

scientific article

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

scientific article

Enforced expression of KDR receptor promotes proliferation, survival and megakaryocytic differentiation of TF1 progenitor cell line.

scientific article published on January 2006

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.

scientific article published on August 2007

Epigenetic immunomodulation of hematopoietic malignancies.

scientific article

Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma.

scientific article published in May 2010

Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

scientific article published in March 2015

Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications.

scientific article

Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.

scientific article published on June 2007

Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".

scientific article published on 3 June 2013

Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT).

scientific article published on 16 June 2017

ICOS Expression as Immunologic Marker in Immune Activating Monoclonal Antibodies.

scientific article published on January 2016

Immune checkpoint blockade in malignant mesothelioma

scientific article published on 24 February 2015

Immune checkpoint blockade in malignant mesothelioma: A novel therapeutic strategy against a deadly disease?

scientific article published on 3 January 2014

Immune checkpoint therapy of mesothelioma: Pre-clinical bases and clinical evidences

scientific article published on 12 July 2017

Immunophenotypic features of acute myeloid leukemias overexpressing the interleukin 3 receptor alpha chain.

scientific article published in August 2004

Increased concentration of circulating acid glycosaminoglycans in chronic lymphocytic leukaemia and essential thrombocythaemia

scientific article published on 01 January 1998

Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy).

scientific article published on 18 December 2010

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.

scientific article

Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

scientific article published on 11 March 2014

Levels of soluble angiogenin in chronic myeloid malignancies: clinical implications.

scientific article published in June 2004

Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme.

scientific article published on 17 April 2013

Lymphocytes from patients with early stage of B-cell chronic lymphocytic leukaemia and long survival synthesize decorin

scientific article published on 07 August 2006

Methylation-regulated expression of cancer testis antigens in primary effusion lymphoma: immunotherapeutic implications.

scientific article published on February 2005

New horizons from immunotherapy in malignant pleural mesothelioma.

scientific article published in January 2018

Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy

scientific article published on 06 April 2020

Prevalence of hypophysitis in a cohort of patients with metastatic melanoma and prostate cancer treated with ipilimumab

scientific article published on 12 April 2017

Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients.

scientific article published on 8 May 2017

Soluble angiogenic factors: implications for chronic myeloproliferative disorders

scientific article published on 01 March 2002

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study

scientific article published on 23 December 2014

Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond.

scientific article published on October 2012

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.

scientific article published on 17 July 2017

Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial

scientific article published on 11 September 2013

Paulina is supported by:

About Paulina

Help